Llanos, Anastacio C.

HRN: 22-55-99  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/05/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/05/2023
02/11/2023
IVT
4.5 G
Q8
Tetanus Infection; T/c CAP-MR, UTI
Waiting Final Action 

Indication:  EmpiricEmpirical Escalation    Type of Infection:  Urinary TractPneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: